48 results on '"Oza, Noriko"'
Search Results
2. Development of performance indicators for hepatitis countermeasures as a tool for the assessment and promotion of liver cancer prevention in Japan
3. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
4. Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)
5. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort
6. Applicability of APRI and FIB-4 as a transition indicator of liver fibrosis in patients with chronic viral hepatitis
7. Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016
8. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
9. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report
10. Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance
11. Clinical characteristics of immunoglobulin IgG4-related sclerosing cholangitis: Comparison of cases with and without autoimmune pancreatitis in a large cohort
12. Efficacy of pegylated interferon plus ribavirin in combination with corticosteroid for two cases of combined hepatitis C and autoimmune hepatitis
13. Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C
14. Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C
15. Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load
16. Efficacy of ezetimibe for reducing serum low-density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non-alcoholic fatty liver disease
17. A pilot trial of body weight reduction for nonalcoholic fatty liver disease with a home-based lifestyle modification intervention delivered in collaboration with interdisciplinary medical staff
18. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis
19. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
20. Mo1142 MACHINE LEARNING-BASED MODEL FOR PREDICTION AND FEATURE ANALYSIS OF RECURRENCE IN PANCREATIC NEUROENDOCRINE TUMORS G1/G2
21. Clinical practice of acute pancreatitis in Japan: An analysis of nationwide epidemiological survey in 2016
22. Quality of Life During Chemotherapy in Japanese Patients with Unresectable Advanced Pancreatic Cancer
23. Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009–2017
24. Eradication of hepatitis C virus by interferon improves whole-body insulin resistance and hyperinsulinaemia in patients with chronic hepatitis C
25. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation
26. Waist circumference correlates with hepatic fat accumulation in male Japanese patients with non-alcoholic fatty liver disease, but not in females
27. An Unusual Case of Acute Liver Failure Caused by Adjuvant Oral Tegafur-Uracil with Folinate Therapy for Colon Cancer Patient: a Case Report
28. Nationwide survey on activities of regional core centers for the management of liver disease in Japan: Cumulative analyses by the Hepatitis Information Center 2009–2017.
29. Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease
30. Current activities and future directions of comprehensive hepatitis control measures in Japan: The supportive role of the Hepatitis Information Center in building a solid foundation
31. Epidemiological survey of hemoglobin A1c and liver fibrosis in a general population with non‐alcoholic fatty liver disease.
32. Impact of Body Weight Reduction via Diet and Exercise on the Anti-Viral Effects of Pegylated Interferon Plus Ribavirin in Chronic Hepatitis C Patients with Insulin Resistance: A Randomized Controlled Pilot Trial
33. Efficacy of ezetimibe for reducing serum low‐density lipoprotein cholesterol levels resistant to lifestyle intervention in patients with non‐alcoholic fatty liver disease
34. Impairment of health-related quality of life in patients with chronic hepatitis C is associated with insulin resistance
35. Metabolic factors are associated with serum alanine aminotransferase levels in patients with chronic hepatitis C
36. Successful cyclosporine treatment for a case with acute-onset autoimmune hepatitis presenting as severe type
37. The utility of natural human interferonβ in a case of chronic hepatitis C with a history of peg-interferonα2a related erythema multiforme
38. 13 Impact of Diet and Exercise Intervention On Insulin Resistance and Early Virological Response to Pegylated Interferon Plus Ribavirin in Patients with Chronic Hepatitis C
39. Whole-Body Insulin Sensitivity Index Is a Highly Specific Predictive Marker for Virological Response to Peginterferon Plus Ribavirin Therapy in Chronic Hepatitis C Patients with Genotype 1b and High Viral Load
40. M1766 Waist Circumference Correlates with Hepatic Fat Accumulation in Male Japanese Patients with Nonalcoholic Fatty Liver Disease, But Not in Females
41. S1929 Visceral Fat Accumulation and Insulin Resistance Are Risk Factors for Increase in ALT in Chronic Hepatitis C in Males But Not in Females
42. Evaluation of hepatitis B patients under treatment with nucleoside analogues by COBAS TaqMan HBV Test
43. A case of portal hypertension caused by intrahepatic arterio-portal fistula formed after percutaneous liver biopsy 35 years previously, markedly improved by transcatheter arterial embolization against the fistula
44. S2065 Minimal Visceral Fat Accumulation Is a Prerequisite for a Persistent Normal Serum ALT Level in Chronic Hepatitis C Patients.
45. [Case of Acute Pancreatitis during Eribulin Mesilate Therapy for Metastasis of Breast Cancer].
46. [A case of liver abscess with meningitis and endophthalmitis: invasive liver abscess syndrome].
47. Presence of esophageal varices is a risk factor for non-hemorrhagic death of hepatocellular carcinoma patients treated with radiofrequency ablation.
48. [Spontaneous esophageal rupture with liver cirrhosis ruptured atypical location postoperaive endoscopic injection sclerotherapy, and treated endoscopically].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.